Publications by authors named "Misaki Tasaka"
Int J Clin Oncol
August 2023
Article Synopsis
- A study investigated the link between prior bevacizumab (BEV) therapy and the development of proteinuria in patients with metastatic colorectal cancer (mCRC) receiving ramucirumab (RAM) treatment.
- Results showed that patients with prior BEV treatment had a significantly higher risk of developing grade 2-3 proteinuria and a greater rate of RAM discontinuation due to related toxicities compared to those without prior BEV.
- The findings suggest that using FOLFIRI plus RAM soon after BEV treatment may worsen proteinuria and negatively affect overall survival, particularly if initiated within 55 days after BEV therapy.
